Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro

Matou, Sabine, Helley, Dominique, Chabut, Delphine, Bros, Andrée and Fischer, Anne-Marie (2002) Effect of fucoidan on fibroblast growth factor-2-induced angiogenesis in vitro. Thrombosis Research, 106 (4-5). pp. 213-221. ISSN 0049-3848

Preview

Accepted Version Available under License Creative Commons Attribution Non-commercial No Derivatives. Download (512kB) | Preview

Abstract

Fucoidans are sulfated polysaccharides extracted from brown marine algae. A purified fucoidan fraction exhibits the same venous antithrombotic activity as heparin in rabbits, but with a lower anticoagulant effect. Because of its heparin-like structure, we postulated that fucoidan might modulate heparin-binding angiogenic growth factor activity. We thus studied its effect, at antithrombotic concentrations, on fibroblast growth factor (FGF)-2-induced proliferation and differentiation of human umbilical vein endothelial cells. The fucoidan effect on endothelial cell differentiation was evaluated by studying the expression of surface proteins (i.e. integrin, adhesion molecule) known to be modulated by FGF-2 and involved in angiogenesis, and by quantifying closed areas delimited by vascular tubes formed on reconstituted basement membrane. Fucoidan had no modulatory effect on the mitogenic activity of FGF-2, but significantly increased tubular structure density induced by FGF-2. Fucoidan alone increased α6 integrin subunit expression with only partially organized tubular structure. In the presence of FGF-2, fucoidan enhanced α6, β1 and PECAM-1 and inhibited αvβ3 integrin expression. Heparin had no effect in these systems. The most striking effect of fucoidan was observed on α6 expression and tube formation was abolished by monoclonal anti-α6 antibodies. Fucoidan plus FGF-2 effect on α6 expression was markedly decreased by monoclonal anti-FGF-2 antibodies, indicating that fucoidan acts mainly via FGF-2. These results show that, at antithrombotic concentrations, contrary to heparin, fucoidan can enhance vascular tube formation induced by FGF-2 with a modulation of the expression of surface proteins (mainly α6) involved in angiogenesis.